2023
DOI: 10.1016/j.autrev.2023.103286
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 and autoimmune bullous diseases: Lessons learned

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…Although they were not enriched in autoreactive B cells, two distinct memory populations (CD80+/ISG15+ and CD11c+/SOX5+/T-bet+/−) with signs of autoreactivity were identified, which were considered to be the source of COVID-19 autoantibodies [ 88 ]. Indeed, the evidence of the development of autoimmune conditions following COVID-19 has accumulated during the past few years [ 44 , 89 , 90 , 91 , 92 , 93 , 94 , 95 ]. In addition, we found a correlation between IL-21 and CVID severity score in patients with CVID.…”
Section: Discussionmentioning
confidence: 99%
“…Although they were not enriched in autoreactive B cells, two distinct memory populations (CD80+/ISG15+ and CD11c+/SOX5+/T-bet+/−) with signs of autoreactivity were identified, which were considered to be the source of COVID-19 autoantibodies [ 88 ]. Indeed, the evidence of the development of autoimmune conditions following COVID-19 has accumulated during the past few years [ 44 , 89 , 90 , 91 , 92 , 93 , 94 , 95 ]. In addition, we found a correlation between IL-21 and CVID severity score in patients with CVID.…”
Section: Discussionmentioning
confidence: 99%